Devaflen XR 100 Tablet contains Desvenlafaxine 100mg, an extended-release formulation belonging to the SNRI (Serotonin-Norepinephrine Reuptake Inhibitor) class. It is commonly prescribed for managing major depressive disorder (MDD), anxiety symptoms, mood instability, and emotional stress-related imbalances.
The XR formulation ensures better symptom control, improved neurotransmitter balance, sustained release, and enhanced patient compliance with once-daily dosing.
Devaflen XR 100 Tablet falls under the neuropsychiatry and mental wellness segment, widely prescribed by psychiatrists, clinical psychologists, and general physicians.
For PCD pharma franchise partners, stockists, and export distributors, Devaflen XR 100 Tablet offers strong market potential due to increasing mental health awareness and continuous prescription demand. It is available for bulk purchase, private label manufacturing, PCD franchise allocation, institutional supply, and export across India.